The role of ARHGAP25 might be particularly pronounced in MSI-high CRC, potentially leading to increased tumor invasiveness and metastatic capacity due to heightened mutation rates affecting cell motility. The gene discussed is ARHGAP25; the disease is colorectal carcinoma.